Our 2025 Joint Mandate Letter

A letter from the Resilient Healthcare Coalition to the Prime Minister of Canada that was sent on May 22, 2025. If you are interested in joining the growing list of supporters, please email info@resilienthealthcare.ca.

Dear Prime Minister, 

We are writing to you today as members and allies of the Resilient Health Coalition (RHC), a collaborative of health system partners committed to providing the leadership, insights, and solutions required to make Canadian health systems stronger and more resilient. 

The RHC brings together a diverse group of health system leaders from industry, research, and patient groups across the not-for-profit and private sectors. Our mission is to create Canadian healthcare systems that improve patient care and health outcomes by evolving to become faster, nimbler, and better able to absorb future shocks. 

To increase the resilience of Canadian health systems, the RHC is committed to working with a wide range of partners to accomplish two fundamental goals: First, optimizing the use of healthcare data to better-inform healthcare decisions; and second, expanding and accelerating access to innovative health technologies – from vaccines and diagnostics to therapeutics and medical devices. 

Following the last federal election In October 2021, the RHC authored a hypothetical Joint Mandate Letter (JML) to the incoming Ministers of Health and Innovation, Science and Economic Development (ISED). Four years later, we have updated the JML to capture 10 bold, compelling and essential policy recommendations that can only be accomplished through the collaborative efforts of your new Ministers of Health and Industry. 

Please find our Mandate Letter attached to this letter. We are confident that its recommendations will help your government help support not only more resilient health but also a vibrant life sciences sector that advances the health and wealth of all Canadians. 

The RHC would appreciate the opportunity to meet and consult with officials from your office to not only expand on our recommendations, but also explore how the Coalition can best share ideas, insights and advice from across the broader healthcare and life sciences ecosystem. 

We look forward to your reply, and we thank you in advance for your time and consideration. 

Sincerely, 

Jason Field, President and CEO, Life Sciences Ontario, Co-Chair, Resilient Healthcare Coalition 

Eva Villalba, Executive Director, Coalition Priorité Cancer au Québec, Co-Chair, Resilient Healthcare Coalition 

Siân Bevan, Chief Science Officer, Arthritis Society Canada, RHC Member 

Louise Binder, Health Policy Consultant, Save Your Skin Foundation, RHC Member 

Connie Côté, CEO, Health Charities Coalition of Canada, RHC Member 

Ugar Gunaydin, Vice-President, General Manager, Amgen 

Ryan Lock, Senior Director, GSK Canada, RHC Member 

Beth Kidd, Executive Director, Health Coalition of Alberta, RHC Member 

Cate Murray, President and CEO, Stem Cell Network, RHC Member 

Jonathan Pratt, Directeur général, Regroupement québécois des maladies orphelines (RQMO), RHC Member 

Barry Stein, President, Colorectal Cancer Canada, RHC Member 

Carlene Todd, Vice President, Access, Hoffmann-La Roche Limited, RHC Member 

Jennifer Van Gennip, Executive Director, Network of Rare Blood Disorder Organizations, RHC Member 

Michelle Burleigh, Co-Chair, Canadian Immunocompromised Advocacy Network 

Michele D’Elia, Executive Director, Medical, Access and Policy, Roche Diagnostics - Division of Hoffmann-La Roche Limited 

Sarah Ford, CEO, Canadian Hemophilia Society 

Dave Gallson, Executive Director, Mood Disorders Society of Canada 

Dana Gies, Executive Director, Canadian Skin Patient Alliance 

Mike Hamilton, CEO, GE HealthCare 

Rob Henderson, President and CEO, BioTalent Canada 

Benoît Larose, CEO, BioQuebec 

Margaret Melandon, President and CEO, Horizon Health Network 

Stéphanie Michaud, President and CEO, BioCanRx 

Jennifer Nebesky, President & CEO, Liver Canada 

Geoff Pradella, CEO, Kids Brain Health Network 

Laurie Proulx, Managing Director, Canadian Arthritis Patient Alliance 

Filomena Servidio-Italiano, President and CEO, Colorectal Cancer Resource and Action Network 

Allison B. Sekuler, President and Chief Scientist, Centre for Aging + Brain Health Innovation 

Leah Stephenson, Strategic Lead, All.Can Canada 

Breanne Stewart, Network Director, RareKids-CAN 

Robb Stoddard, President and CEO, BioAlberta 

Dr. Steven Theriault, CEO, Cytophage Technologies Inc. 

Tania Vrionis, CEO, Ovarian Cancer Canada 

Christine Williams, Acting President and Head, Implementation Science, Ontario Institute for Cancer Research 

Durhane Wong-Rieger, President and CEO, Canadian Organization for Rare Disorders 

Fatih Yedikardeş, Country Manager, Daiichi Sankyo Pharma Canada Ltd.